RT – 40 mg

Advanced Triple-Receptor Agonist | Research Peptide

RT is an investigational peptide attracting significant scientific interest for its unique triple-receptor mechanism.

Unlike compounds that target just one or two metabolic pathways, RT simultaneously activates three important hormone receptors:

• GLP-1 (Glucagon-Like Peptide-1): Involved in appetite regulation, satiety and blood glucose control.

• GIP (Glucose-Dependent Insulinotropic Polypeptide): Plays an important role in insulin secretion and metabolic regulation.

• Glucagon: Involved in energy metabolism, glucose production and energy expenditure.

This triple-action mechanism has made RT a major focus of ongoing clinical research into obesity, metabolic health and glucose regulation.

Key Research Areas

• Appetite and satiety signalling

• Body-weight regulation and energy balance

• Glucose metabolism and insulin response

• Metabolic efficiency and energy expenditure

• Interactions between GLP-1, GIP and glucagon pathways

Product Information

Product: RT
Strength: 40 mg
Classification: Investigational triple-receptor agonist
Brand: Helix Bio-Science

Important Research Disclaimer

RT is an investigational compound and has not been approved for general medical use. Its safety and efficacy are still being evaluated through clinical trials.

For research use only. Not for human or animal consumption. Not intended to diagnose, treat, cure or prevent any disease.